Quick Takeaways
- Joe Lonsdale filed SCHEDULE 13G/A for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI).
- Disclosed ownership: 1%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"Joe Lonsdale disclosed 1% ownership in Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 8VC Fund I, L.P. | 1% | 249,827 | 0 | 249,827 | /s/ Joe Lonsdale | Joe Lonsdale, Managing Member of 8VC GP I, LLC, the general partner of 8VC Fund I, L.P. | |
| 8VC Entrepreneurs Fund I, L.P. | 0% | 3,928 | 0 | 3,928 | /s/ Joe Lonsdale | Joe Lonsdale, Managing Member of 8VC GP I, LLC, the general partner of 8VC Entrepreneurs Fund I, L.P. | |
| 8VC GP I, LLC | 1% | 253,755 | 0 | 253,755 | /s/ Joe Lonsdale | Joe Lonsdale, Managing Member | |
| Joe Lonsdale | 1% | 253,755 | 253,755 | 0 | /s/ Joe Lonsdale | Joe Lonsdale |